Barry Richard (CIK 1562371) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy SRPT (16,875 shares), Buy SAVA (150,000 shares), Buy SAVA (73,385 shares), Buy SAVA (7,172 shares), Buy SAVA (5,400 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 16,875 | $0 |
| 2025-11-24 | CASSAVA SCIENCES INC (SAVA) | President & CEO | Buy | 150,000 | $414,000 |
| 2025-11-20 | CASSAVA SCIENCES INC (SAVA) | President & CEO | Buy | 73,385 | $201,809 |
| 2025-09-23 | CASSAVA SCIENCES INC (SAVA) | President & CEO | Buy | 7,172 | $16,352 |
| 2025-09-22 | CASSAVA SCIENCES INC (SAVA) | President & CEO | Buy | 5,400 | $11,502 |
| 2025-09-22 | CASSAVA SCIENCES INC (SAVA) | President & CEO | Buy | 185,233 | $414,922 |
| 2025-09-22 | CASSAVA SCIENCES INC (SAVA) | President & CEO | Buy | 400 | $900 |
| 2025-09-22 | CASSAVA SCIENCES INC (SAVA) | President & CEO | Buy | 46,908 | $107,419 |
| 2025-05-19 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 12,350 | $402,980 |
| 2025-05-15 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 9,746 | $245,404 |
| 2025-05-15 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 10,500 | $143,955 |
| 2025-03-11 | Sarepta Therapeutics, Inc. (SRPT) | Director | Buy | 2,383 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05